Clinical Trial Update: Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial from Roswell Park Cancer Institute is evaluating bipolar androgen therapy to restore sensitivity to androgen deprivation therapy in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma | Phase 1 | Status: RECRUITING